Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A List

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Leukemia|December 1, 2010
Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuriaC L O'Keefe, C Sugimori, M Afable, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?M A List, J Stracks, L Colangelo, et al.
Head & Neck|February 6, 2004
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatientsMarcy A List, Judith Lee Rutherford, John Stracks, et al.
Cancer Journal (Sudbury, Mass.)|April 28, 2001
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancerC A Mantz, E E Vokes, K Stenson, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 22, 2008
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancerJoseph K Salama, Kerstin M Stenson, Marcy A List, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckEzra E W Cohen, Madeleine A Kane, Marcy A List, et al.
Bone Marrow Transplantation|February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSFC S Rosenfeld, B Bolwell, A LeFever, et al.
Science (New York, N.Y.)|April 1, 2006
High-performance high-TC superconducting wiresS Kang, A Goyal, J Li, et al.
Journal of the National Cancer Institute|September 18, 2003
Is patient travel distance associated with survival on phase II clinical trials in oncology?Elizabeth B Lamont, Davinder Hayreh, Kate E Pickett, et al.
Bone Marrow Transplantation|June 23, 2009
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantationT Field, J Perkins, Y Huang, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Leukemia|December 1, 2010
Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuriaC L O'Keefe, C Sugimori, M Afable, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?M A List, J Stracks, L Colangelo, et al.
Head & Neck|February 6, 2004
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatientsMarcy A List, Judith Lee Rutherford, John Stracks, et al.
Cancer Journal (Sudbury, Mass.)|April 28, 2001
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancerC A Mantz, E E Vokes, K Stenson, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 22, 2008
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancerJoseph K Salama, Kerstin M Stenson, Marcy A List, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckEzra E W Cohen, Madeleine A Kane, Marcy A List, et al.
Bone Marrow Transplantation|February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSFC S Rosenfeld, B Bolwell, A LeFever, et al.
Science (New York, N.Y.)|April 1, 2006
High-performance high-TC superconducting wiresS Kang, A Goyal, J Li, et al.
Journal of the National Cancer Institute|September 18, 2003
Is patient travel distance associated with survival on phase II clinical trials in oncology?Elizabeth B Lamont, Davinder Hayreh, Kate E Pickett, et al.
Bone Marrow Transplantation|June 23, 2009
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantationT Field, J Perkins, Y Huang, et al.
Pageof 16